Prot# 331-10-237: A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults with Schizophrenia

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/126/1/14

Funding

  • Quintiles, Inc. (331-10-237)
  • Otsuka Pharmaceutical Development & Commercialization, Inc. (331-10-237)